Korean Circ J.
2024 Jun;54(6):361-362. 10.4070/kcj.2024.0999.
Erratum: Correction of Figures in the Article “Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway”
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- 2Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2556536
- DOI: http://doi.org/10.4070/kcj.2024.0999
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
- Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5
- Sulfatase 1 mediates the inhibitory effect of angiotensin II type 2 receptor inhibitor on angiotensin II-induced hypertensive mediator expression and proliferation in vascular smooth muscle cells from spontaneously hypertensive rats
- Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC
- Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase
